Abstract: A furniture arrangement includes a worksurface having a side edge and opposite front and rear edges, where the worksurface is vertically spaced so as to define leg space beneath each of the front and rear edges. A chair is positioned adjacent the rear edge and has a backrest defined by first and second back support portions extending in first and second directions. The first and second back support portions are substantially perpendicular. The first back support portion has an end positioned adjacent the rear edge such that the second back support portion is spaced from the rear edge and defines an ingress and egress opening between the second back support portion and the rear edge. The first and second back support portions and the rear edge define a U-shaped occupancy space in plan view.

Abstract: Implementations of the disclosure include a lid for covering a vessel, having a cover portion and a base portion, and methods of operating such a lid. The cover portion and the base portion may be separate individual pieces. In some implementations, the cover portion is adapted to slide along the base portion between an open position and a closed position. In some instances, the cover portion slides along an arcuate path. In some implementations, when the cover portion is in a cover-removal position, it can be separated from the base portion without separating the base portion from the vessel. In such implementations, when the cover portion is in a lid-removal position, the cover portion and the base portion can be separated from the vessel while remaining attached to one another.

Abstract: A suspension chair includes a first and second back support portion having first and second suspension elements extending in first and second substantially perpendicular directions respectively. The first and second suspension elements are tensioned so as to provide first and second normal biasing forces to the first and second body support portions. In one embodiment, the chair includes a fixed support defining an upper portion and a pivotable side support. A fabric layer covers at least a portion of the fixed support and a front surface of the side support. Various furniture arrangements and modular furniture kits incorporating one or more chairs, desks and/or tables are provided.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: A suspension chair includes a first and second back support portion having first and second suspension elements extending in first and second substantially perpendicular directions respectively. The first and second suspension elements are tensioned so as to provide first and second normal biasing forces to the first and second body support portions. In one embodiment, the chair includes a fixed support defining an upper portion and a pivotable side support. A fabric layer covers at least a portion of the fixed support and a front surface of the side support. Various furniture arrangements and modular furniture kits incorporating one or more chairs, desks and/or tables are provided.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.

Abstract: This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing. The invention also provides arginine polymers and arginine homopolymers for use in organ perfusate and preservation solutions.